These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 378352)

  • 1. A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human sera.
    Howard DR; Taylor CR
    Cancer; 1979 Jun; 43(6):2279-87. PubMed ID: 378352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells.
    Howard DR; Taylor CR
    Oncology; 1980; 37(3):142-8. PubMed ID: 6244524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunofluorescence studies of benign and malignant human mammary tissue.
    Richman AV
    J Natl Cancer Inst; 1976 Aug; 57(2):263-7. PubMed ID: 826647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions.
    Walsh R; Peston D; Shousha S
    Arch Pathol Lab Med; 2001 Jun; 125(6):781-4. PubMed ID: 11371230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunofluorescence studies in stomach and breast carcinomas and benign breast diseases].
    Kasper M
    Acta Histochem; 1984; 75(1):37-45. PubMed ID: 6438999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody 323/A3: a marker for the presence of breast carcinoma.
    Courtney SP; Williams S; Mansel RE
    Cancer Lett; 1991 May; 57(2):115-9. PubMed ID: 2025884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
    Wittekind C; von Kleist S; Sandritter W
    Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
    Whitwell HL; Hughes HP; Moore M; Ahmed A
    Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues.
    Kashiwase Y; Morioka J; Inamura H; Yoshizawa Y; Usui R; Kurosawa M
    Int Arch Allergy Immunol; 2004 Jul; 134(3):199-205. PubMed ID: 15178888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Ca 1 antibody in the diagnosis of invasive breast cancer.
    Clough DG; Coghill GR; Holley MP
    J Clin Pathol; 1984 Jan; 37(1):10-3. PubMed ID: 6368594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative immunohistological studies of the localization of the carcinoembryonic antigen in benign and malignant breast tissue].
    Wittekind C; von Kleist S; Sandritter W
    Acta Histochem Suppl; 1982; 25():83-7. PubMed ID: 6806865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging.
    Jacobs MA; Barker PB; Bluemke DA; Maranto C; Arnold C; Herskovits EH; Bhujwalla Z
    Radiology; 2003 Oct; 229(1):225-32. PubMed ID: 14519877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 accumulation in benign breast biopsy specimens.
    Younes M; Lebovitz RM; Bommer KE; Cagle PT; Morton D; Khan S; Laucirica R
    Hum Pathol; 1995 Feb; 26(2):155-8. PubMed ID: 7860045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to an altered IgG in human breast cancer.
    Humphrey LJ; Volenec PJ; Volenec FJ; Cross D
    J Surg Oncol; 1977; 9(1):29-37. PubMed ID: 839795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of support vector machine-recursive feature elimination algorithm in Raman spectroscopy for differential diagnosis of benign and malignant breast diseases].
    Zhang H; Fu T; Zhang Z; Fan Z; Zheng C; Han B
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):582-6. PubMed ID: 25430023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.